Dr Austin Kulasekararaj discusses Phase 3 results of ALXN 1210
Posted on
Dr Austin Kulasekararaj, consultant haematologist Kings College Hospital London, and ALXN 1210 investigator, said, “ALXN1210 could provide an effective alternative choice for treatment of both treatment-naïve PNH patients and also switching […]
Read more About Dr Austin Kulasekararaj discusses Phase 3 results of ALXN 1210